Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies
Open Access
- 1 August 2017
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 11, 2443-2452
Abstract
This study was aimed to enhance the dissolution rate, oral bioavailability and analgesic potential of the aceclofenac (AC) in the form of nanosuspension using cost-effective simple precipitation–ultrasonication approach. The nanocrystals were produced using the optimum conditions investigated for AC. The minimum particle size (PS) and polydispersity index was found to be 112±2.01 nm and 0.165, respectively, using hydroxypropyl methylcellulose (1%, w/w), polyvinylpyrrolidone K30 (1%, w/w) and sodium lauryl sulfate (0.12%, w/w). The characterization of AC was performed using zeta sizer, scanning electron microscopy, transmission electron microscopy, powder X-ray diffraction and differential scanning calorimetry. The saturation solubility of the AC nanocrystals was substantially increased 2.6- and 4.5-fold compared to its unprocessed active pharmaceutical ingredient in stabilizer solution and unprocessed drug. Similarly, the dissolution rate of the AC nanocrystals was substantially enhanced compared to its other counterpart. The results showed that >88% of AC nanocrystals were dissolved in first 10 min compared to unprocessed AC (8.38%), microsuspension (66.65%) and its marketed tablets (17.65%). The in vivo studies of the produced stabilized nanosuspension demonstrated that the Cmax were 4.98- and 2.80-fold while area under curve from time of administration to 24 h (AUC0→24 h) were found 3.88- and 2.10-fold greater when compared with unprocessed drug and its marketed formulation, respectively. The improved antinociceptive activity of AC nanocrystals was shown at much lower doses as compared to unprocessed drug, which is purely because of nanonization which may be attributed to improved solubility and dissolution rate of AC, ultimately resulting in its faster rate of absorption.Keywords
This publication has 36 references indexed in Scilit:
- Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluationDrug Design, Development and Therapy, 2016
- Nanosizing of drugs: Effect on dissolution rate2015
- Bottom-up approaches for preparing drug nanocrystals: Formulations and factors affecting particle sizeInternational Journal of Pharmaceutics, 2013
- Physical and chemical stability of drug nanoparticlesAdvanced Drug Delivery Reviews, 2011
- Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery systemJournal of Pharmacy and Bioallied Sciences, 2011
- Nanocrystal technology, drug delivery and clinical applicationsInternational Journal of Nanomedicine, 2008
- Nucleation and crystal growth in supersaturated solutions of a model drugJournal of Colloid and Interface Science, 2008
- Nanosizing — Oral formulation development and biopharmaceutical evaluationAdvanced Drug Delivery Reviews, 2007
- Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized techniqueEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Development and Evaluation of Glyburide Fast Dissolving Tablets Using Solid Dispersion TechniqueDrug Development and Industrial Pharmacy, 2004